跨国企业在华布局新升级 将推动跨境医药供应链标准化和现代化

Core Insights - Novo Nordisk has launched a modern warehouse and logistics center at Shanghai Pudong International Airport, enhancing its supply chain capabilities for diabetes and obesity treatments [1][3] Group 1: Warehouse and Logistics Center - The new warehouse and logistics center is a significant upgrade in Novo Nordisk's operations in China, expected to receive drug and medical device operating licenses by the end of 2024 [3] - The facility features temperature-controlled storage systems, including 2℃-8℃ and 15℃-25℃ zones, and is equipped with advanced management and monitoring systems to ensure safety and efficiency [3] - This center is a key component of Novo Nordisk's supply chain in China, reinforcing Shanghai's role as a commercial and innovation hub for the company [3][4] Group 2: Innovation and Collaboration - The warehouse is part of Novo Nordisk's Open Innovation Center in China, which aims to foster collaboration across various fields, including digital health and logistics [4] - The company has introduced 22 innovative drugs and 11 injection devices to China over its 31 years in the market, with Shanghai serving as a pivotal point for its ongoing engagement with the Chinese market [4][5] Group 3: Upcoming Events and Product Developments - At the upcoming China International Import Expo, Novo Nordisk will showcase its latest developments, including the integration of cardiovascular benefits into the product instructions for its weight management drug [5] - The company will also present clinical research findings on innovative combination therapies and long-acting growth hormone treatments at the expo [5]